Smart Living, a subsidiary of Smart Global, a $2 billion (USD) diversified conglomerate that serves over 25 million customers around the world, announced a collaborative agreement with Stemedica Cell Technologies. The companies will introduce breakthrough technology and dynamic educational outreach focused on health care initiatives to countries around the world.
Smart living is a unique, holistic and mindful approach to wellness through preventive and curative interventions. It is a way of looking at life from different perspective which transcends beyond religion, nationality, and gender. It offers premium, multidimensional services for wellness in the field of yoga, meditation, vipassana, age management, stress management, aesthetics medicine, wellness spa, wearable health monitoring, mobile health care applications and stem cells
Smart Living is a vertical of Smart Health City which will be a complete health care destination offering services like Multispecialty hospital, Medical office building, Medical Rehabilitation Centre, International patients Centre, Medical Education and Training, Clinical Research, on Campus Staff Residence, Research & Technology Centre expanded over 15 acres and located at Saket heart of Delhi.
Swati Saxena, MD Programme Director, Smart Living said, What sets Smart Living apart and unique from others is that it provides integrated and converged facilities with strong scientific evidence paired with mindfulness under the domain of one comprehensive programme, where health and wellness are achieved in step by step methodic fashion guided by medical experts.
Smart Living programmes are designed in such a way that it integrates mindfulness and scientific approaches that take healthy living to the next level. Smart living teaches individuals to explore their inner depths to find gems of love, happiness, wellness, patience and compassion in line with our tag line enjoy life 24*7.
Stemedica Cell Technologies, Inc. is a specialty biopharmaceutical company that is committed to the manufacturing and development of best-in-class allogeneic adult stem cells and stem cell factors for use by approved research institutions and hospitals for pre-clinical and FDA approved clinical (human) trials. The company has a wide range of breakthrough technology in the regenerative medicine field and operates in several countries.
Dr. Bhupendra Kumar (BK) Modi, PhD, Chairman, Smart Global and Founder of Smart Living, said, Were delighted to invest with Stemedica. Our objective is to implement sophisticated technologies, new and improved innovations and encourage research for the betterment of health of the society. As Smart Living continues its worldwide efforts to promote health and wellbeing, Stemedicas leadership in the regenerative health movement is an ideal fit for our efforts.
Roger A. Howe, PhD, utive Chairman, Stemedica, said about the collaboration, This is an excellent opportunity to combine our technology and our commitment to healthy living, with Dr. Modis vision of Smart Living which has the objective of bringing healthy lifestyles to every community around the world. Stemedica will participate in a series of ongoing One World Conferences. Together with Smart Living we will highlight the importance of new technologies that lead to medical breakthroughs, including Stemedicas stem cell technology.
As part of the agreement, Mr. Ozi Amanat, Chief Investment Officer, Smart Global will become a business advisor to Stemedica. In accepting the appointment, Mr. Amanat said, Im honored to be working with Stemedica and its leadership. Stemedica is poised to bring the power and potential of regenerative medicine to the world. Its leadership in this field is exciting and I look forward to supporting their continued growth as well as creating maximum value to both organizations through our new partnership.
Smart Living has made an undisclosed investment in Stemedica.